EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 32 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,682,000 | +1.3% | 666,171 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $6,595,000 | +32.8% | 666,171 | +32.1% | 0.01% | +60.0% |
| Q1 2022 | $4,966,000 | +6.3% | 504,171 | +5.3% | 0.01% | +25.0% |
| Q4 2021 | $4,672,000 | +171.9% | 478,669 | +172.5% | 0.00% | +100.0% |
| Q3 2021 | $1,718,000 | +44.1% | 175,681 | +45.1% | 0.00% | +100.0% |
| Q2 2021 | $1,192,000 | – | 121,035 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SkyView Investment Advisors, LLC | 71,773 | $717 | 0.22% |
| EcoR1 Capital, LLC | 200,000 | $1,998,000 | 0.06% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 3,483 | $34,795 | 0.00% |
| Tower Research Capital LLC (TRC) | 657 | $7 | 0.00% |
| DEUTSCHE BANK AG\ | 21,923 | $219,011 | 0.00% |